β-secretase (BACE1) inhibitors from sanguisorbae radix

Archives of Pharmacal Research

Volumn 28, Issue 7, 2005, Pages 799-803

  Lee, Hee Ju ^a   Seong, Yeon Hee ^b   Bae, Ki Hwan ^c   Kwon, Soon Ho ^a   Kwak, Hye Min ^a   Nho, Si Kab ^d   Kim, Kyung A ^d   Hur, Jong Moon ^a   Kyung, Bok Lee ^a   Kang, Young Hwa ^a   Song, Kyung Sik ^a  

^a Kyungpook National University   (South Korea)

^b Chungbuk National University   (South Korea)

^c Chungnam National University   (South Korea)

^d Konyang University   (South Korea)

Author keywords

secretase (BACE1); 1,2,3,4,6 Pentagalloyl D glucopyranoside; Alzheimer's disease; Inhibitor; Sanguisorbae radix; Tellimagrandin II

Indexed keywords

ASPARTIC PROTEINASE; BACE1 PROTEIN, HUMAN; BETA PENTA O GALLOYL GLUCOSE; BETA-PENTA-O-GALLOYL-GLUCOSE; DRUG DERIVATIVE; GALLIC ACID; GLUCOSIDE; PLANT EXTRACT; PROTEINASE; PROTEINASE INHIBITOR; SECRETASE; TANNIN; TELLIMAGRANDIN II;

ALZHEIMER DISEASE; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; DOSE RESPONSE; HUMAN; IC 50; IN VITRO STUDY; ISOLATION AND PURIFICATION; KINETICS; METABOLISM; SANGUISORBA;

ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ENDOPEPTIDASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPEPTIDASES; GALLIC ACID; GLUCOSIDES; HUMANS; HYDROLYZABLE TANNINS; INHIBITORY CONCENTRATION 50; KINETICS; PLANT EXTRACTS; PROTEASE INHIBITORS; SANGUISORBA;

EID: 30544450683     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02977345     Document Type: Article

References (12)

1. Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., and Doan, M. et al., Purification and cloning of amyloid precursor protein β-secretase from human brain. Nature, 402, 533-537 (1999).
2. Citron, M., β-Secretase as a target for the treatment of Alzheimer's disease. J. Neurosci. Res., 70, 373-379 (2002).
3. Feldman, K. S. and Sahasrabudhe, K., Ellagitannin Chemistry. Syntheses of tellimagrandin and a dehydrodigalloyl ethercontaining dimeric gallotannin analogue of coriariin A. J. Org. Chem., 64, 209-216 (1999).
4. Ghosh A. K., Bilcer G., Harwood C., Kawahama R., Shin, D., Hussain, K. A., Hong, L., Loy, J. A., Nguyen, C., Koelsch, G., Ermolieff, J., and Tang, J., Structure-based design: potent inhibition of human brain memapsin 2 (β-secretase). J. Med. Chem., 44, 2865-2868 (2001).
5. Ghosh, A. K., Shin, D., Downs, D., Koelsch, G., Lin, X., Ermolieff, J., and Tang, J., Design of potent inhibitors for human brain memapsin 2 (β-secretase). J. Am. Chem. Soc., 122, 3522-3523 (2000).
6. Glenner, G. G. and Wong, C. W., Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun., 120, 885-890 (1984).
7. Jeon, S.-Y., Bae, K-.H., Seong, Y.-H., and Song, K.-S., Green tea catechins as a BACE1 (β-secretase) inhibitor. Bioorg. Med. Chem. Lett., 13, 3905-3908 (2003).
8. Kim, S.-I. and Song, K.-S., 1,2,3,4,6-Pentagalloyl-β-D- glucopyranose, a prolyl endopeptidase inhibitor from Moutan cortex. J. Korean Soc. Agric. Chem. Biotechnol., 43, 158-161 (2000).
9. Lee, V. M.-Y., Balin, B. J., Otvos, L., and Trojanowski, J. Q., A major subunit of paired helical filaments and derivatized forms of normal tau. Science, 251, 675-678 (1991).
10. Terry, R. D., Masliah, E., and Hansen, L. A., The neuropathology of Alzheimer disease and the structural basis of its cognitive alterations, in: R. D. Terry et al. (Ed.), Alzheimer Disease, Lippincott, Williams and Wilkins, Philadelphia, pp. 187-206 (1999).
11. Tung J. S., Davis D. L., Anderson J. P., Walker D. E., Mamo S., Jewett N., Hom R. K., Sinha S., Thorsett E. D., and John V., Design of substrate-based inhibitors of human β-secretase. J. Med. Chem., 45, 259-262, (2002).
12. Vassar, R., β-Secretase (BACE) as a drug target for alzheimer's disease. Advanced Drug Delivery Reviews, 54, 1589-1602 (2002).